Biotech investors are far more selective than they were during the pandemic-era boom, JPMorgan's top EMEA healthcare investment bankers told CNBC. Many biotech companies are now pursuing a dual-track ...
A pair of fuzzy bald eagle chicks are close to reaching a major milestone in their lives, with signs that they are preparing for their first flight out of the nest since they hatched earlier this year ...
It’s not every manager who would keep sending out the utility player when the high-priced free-agent signee is healthy and available. But Braves manager Walt Weiss penciled in Mauricio Dubón again at ...
This is how I’m making eggs from now on | Easy and delicious method Learn a simple and reliable way to cook eggs that delivers great texture and flavor every time. This easy method shows how small ...
Hadi Partovi, founder of Code.org and new CEO of Payam Music, speaking at a Microsoft event in July 2025. (GeekWire Photo / Todd Bishop) Hadi Partovi helped kids around the world learn to code. Next ...
WINDSOR, N.Y. (WBNG) -- The new owner of Big M Supermarket turned to a game show classic to promote the business and reassure the community that the store is not going anywhere. Bobby Singh officially ...
May 1 (Reuters) - Biotech dealmaking is on pace for a bumper year in 2026, with large drugmakers on an acquisition spree to boost their pipelines ahead of upcoming patent losses. The surge appears ...
Big corporate M&A is booming—and banks are earning megasize fees. In 2025, six acquisitions of U.S. public companies included sell-side fees of at least $100 million for a single bank, according to ...
Forget March going out like a lamb. On the M&A landscape, March went out like a lion. In a flurry of activity over the last 12 days of the month, biopharma companies pulled off seven transactions each ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results